Linkage Global launches Phase II clinical research on non-drug cognitive impairment, sleep disorder approaches
UZX•Phase II clinical research begins
Linkage Global launched second-stage clinical research on non-drug approaches for cognitive impairment and sleep disorders.
Results from an earlier two-year observational study were presented, showing some coma patients regained consciousness during follow-up.
The company said the findings remain preliminary, with no controlled trial design, no peer review, and no regulator review of the protocol.
The program signals a push to use research data to guide product development in wellness devices aimed at clinical and consumer markets.
